CorMedix (CRMD) Long-Term Investments (2024 - 2025)
CorMedix (CRMD) reported Long-Term Investments of $23.8 million for Q4 2025, up 22581.9% on a YoY basis from N/an in Q4 2024, and up 3.94% sequentially from $22.9 million in Q3 2025.
CorMedix (CRMD) Long-Term Investments (2024 - 2025) Analysis & Trends
CorMedix (CRMD) has 2 years of Long-Term Investments data on file, last reported at $23.8 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments rose 22581.9% year-over-year to $23.8 million; the trailing twelve-month figure through Dec 2025 stood at $23.8 million (up 22581.9% YoY), and the FY2025 full-year result was $23.8 million, up 22581.9% from the prior year.
- Long-Term Investments rose to $23.8 million in Q4 2025, from $22.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $23.8 million in Q4 2025 to a low of $105000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 23.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.82 Mn |
| Sep 30, 2025 | 22.91 Mn |
| Dec 31, 2024 | 105,000.00 |